Is ₹400 crore ke IPO se GSP Crop Science ka main motive tha apna debt kam karna. Lagbhag ₹170 crore direct debt chukane mein use kiye gaye hain, aur baaki corporate needs ke liye. IPO se pehle company ka debt-to-equity ratio 1.2x tha, jo kaafi zyada mana jaata hai. IPO ke baad company ki valuation lagbhag ₹1,489 crore ki hai aur Price-to-Earnings (P/E) ratio 30x ke aas-paas hai. Yeh PI Industries (30.5x) aur Bayer CropScience (30.2x) ke same level par hai, par UPL (24.6x) se thoda upar.
Stock March 24, 2026 ko NSE aur BSE par list hua. Shuruat mein share price 2.5% se 4% ka modest premium dikha raha tha. Din ke high par toh yeh 13.4% upar bhi gaya tha, par overall listing pressure mein rahi.
Pure IPO ki subscription 1.61 times hui. Qualified Institutional Buyers (QIBs) ne achha interest dikhaya (1.28 times subscribe kiya), lekin retail investors ka participation kafi kam raha, sirf 0.17 times.
Yeh sab tab ho raha hai jab Indian agrochemical market grow kar raha hai (jo 2025 mein $9 billion se 2030 tak $12.7 billion hone ka andaaza hai). Lekin, monsoon par reliance, El Niño jaise climate changes, aur badhte crude oil prices aur global tensions ki wajah se costs increase ho sakti hain.
Analysts ka kehna hai ki GSP Crop Science abhi fair valuation par hai aur turant bade gains ki ummeed kam hai. Investors ko apna debt manage karna aur R&D par focus karna hoga. Stock mein hold karne wale caution ke saath long-term dekh sakte hain.